This inventor holds 1 USPTO granted patent. Top assignee: Yonsei University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Seung Tae Su in Muscular Disease Treatment
Introduction
Seung Tae Su is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of muscular disease treatment through his innovative research and patenting efforts. His work focuses on developing compositions that can prevent or treat muscular diseases and improve muscular functions.
Latest Patents
Seung Tae Su holds a patent for a composition aimed at preventing or treating muscular diseases, or for enhancing muscular functions, which contains ganglioside. The patent details a pharmaceutical composition that can increase the expression of proteins associated with muscle protein synthesis and muscle mass growth in muscle cells. Additionally, it inhibits the expression of enzymes involved in muscle protein degradation at the mRNA level. This innovative approach has the potential to significantly impact the treatment of muscular diseases.
Career Highlights
Seung Tae Su is affiliated with Yonsei University, where he conducts his research and development activities. His academic background and ongoing research contribute to the advancement of knowledge in the field of muscular health. His dedication to innovation is evident in his patent and the potential applications of his work.
Collaborations
Seung Tae Su collaborates with notable colleagues, including Chang Hee Kim and Ji Hee Yoo. These partnerships enhance the research efforts and broaden the scope of their work in muscular disease treatment.
Conclusion
Seung Tae Su's innovative contributions to the field of muscular disease treatment through his patent on ganglioside compositions highlight his commitment to improving health outcomes. His work at Yonsei University and collaborations with fellow researchers further underscore the importance of innovation in addressing muscular health challenges.